Table 1.

Hospitalizations for gout and all causes, 2002 to 2012.

20022003200420052006200720082009201020112012p*
Discharges for gout, n112119108134133131140144187180213
Gout hospitalization, incidence per 100,000 adults9.510.09. 111. 211.010.711.311.514.914.216.70.0002
Total hospitalization, incidence per 100,000 adults17,34817,26917,36917,65617,68918,14718,18617,97118,27818,17818,376< 0.0001
Gout hospitalization, incidence per 100,000 men12.313.212.913.514.415.115.716.022.021.124.3< 0.0001
Gout hospitalization, incidence per 100,000 women6.87.05.38.97.76.57.07.17.97.39.10.14
Gout hospitalization duration, days, median (range)3 (1–44)4 (1–99)5 (1–75)4 (1–36)5 (1–65)4 (1–34)5 (1–40)5 (1–39)5 (1–34)5 (1–52)5 (1–41)
Total hospitalization duration, days, median (range)3 (0–8614)3 (0–2610)3 (0–3273)3 (0–4759)3 (0–7452)3 (0–2666)3 (0–2737)3 (0–5332)3 (0–7383)3 (0–7624)3 (0–3026)
Age at gout hospitalization, yrs, mean (SD)74.3 (14.9)77.5 (10.9)76.3 (11.7)75.8 (12.3)77.2 (10.2)76.2 (13.0)77.4 (11.4)76.7 (11.6)77.6 (12.7)75.6 (14.1)75.0 (13.8)
Gout hospitalization by age group, yrs
  18–4465120654884
  45–641612172219151211192841
  65–84637367758082858910092108
  ≥ 852729233534283840605260
ULT, (%), 6 mos before discharge28 (21)28 (21)38 (27)27 (19)38 (20)47 (26)45 (21)
ULT, (%), 6 mos after discharge31 (23)64 (49)78 (56)35 (24)103 (55)83 (46)94 (44)
Total cost**, 105 US$5.216.86.68.15
  • * P value for trend calculated by linear regression.

  • ** Adjusted for inflation. ULT: urate-lowering therapy.